Recombinant B7-H4 (Alsevalimab Biosimilar) antibody
Reactivity: Human
ELISA, FACS, BLI, Func, SPR
Host: Human
Monoclonal
unconjugated
Recombinant Antibody
-
- Target See all B7-H4 (Alsevalimab Biosimilar) products
- B7-H4 (Alsevalimab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Human
- Expression System
- CHO Cells
-
Clonality
- Monoclonal
-
Conjugate
- This B7-H4 (Alsevalimab Biosimilar) antibody is un-conjugated
- Application
- ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)
- Purpose
- Anti-B7-H4 / VTCN1 Reference Antibody (alsevalimab)
- Characteristics
- Anti-B7-H4 / VTCN1 Reference Antibody (alsevalimab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 104.42 kDa.
- Purity
- >95 %
- Isotype
- IgG1
-
anti-B7-H4 (Alsevalimab Biosimilar) antibody
Research Grade Reactivity: Human ELISA, FACS Host: Human Monoclonal unconjugated Recombinant Antibody
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Comment
-
Conditions: Breast Cancer Ovarian Cancer
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Concentration
- 1 mg/mL
- Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
- Storage
- 4 °C,-80 °C
- Storage Comment
- +4°C,-80°C
-
- Target
- B7-H4 (Alsevalimab Biosimilar)
- Abstract
- B7-H4 (Alsevalimab Biosimilar) Products
- Target Type
- Biosimilar
- Background
- Synonyms: O8E, OV064, B7H4, B7S1, VTCN1, V-set domain-containing T-cell activation inhibitor 1
- Molecular Weight
- 104.42 kDa
- UniProt
- Q7Z7D3
-
You are here:
